Systems-level consequences of low RAF abundance for EGFR-ERK signaling

Sung Hyun Lee1, Paul J Myers1, Max C Mendrzycki1

  • 1Department of Chemical Engineering, University of Virginia, Charlottesville, Virginia.

Biophysical Journal
|January 7, 2026
PubMed

Insights

Low RAF abundance in cancer cells creates signaling bottlenecks, potentially impacting ERK pathway activation and drug resistance. Computational models reveal stochastic RAF dynamics influencing signal propagation.

Area of Science:

  • Cellular signaling pathways
  • Cancer biology
  • Computational modeling

Background:

  • Receptor tyrosine kinases (RTKs) initiate signaling cascades, including the RAF-MEK-ERK pathway, crucial for cell growth and proliferation.
  • RAF proteins are key intermediates in this cascade, but their low abundance in some cancer cells presents an unexplored signaling regime.
  • The functional consequences of limited RAF abundance on epidermal growth factor receptor (EGFR)-ERK pathway dynamics remain unclear.

Purpose of the Study:

  • To investigate the impact of low RAF abundance on EGFR-ERK pathway signaling dynamics using computational models.
  • To explore potential signaling bottlenecks and stochastic effects arising from limited RAF protein levels.
  • To identify key molecular interactions determining pathway behavior in low-RAF conditions.

Main Methods:

  • Development of continuum and stochastic computational models for the EGFR-ERK pathway.
  • Analysis of signaling bottlenecks and stochastic RAF dynamics under varying RAF abundance.
  • Application of parameter sensitivity and Sloppiness analyses to identify critical signaling determinants.

Main Results:

  • Low RAF abundance creates significant signaling bottlenecks between RTKs and ERK, potentially hindering signal propagation.
  • Stochastic RAF dynamics can propagate, particularly affecting low-abundance downstream pathway proteins.
  • RAF bottlenecks were predicted to impede ERK activation by oncogenic RAS mutants.
  • RAS activation and RAS-RAF interactions were identified as critical determinants of signaling in low-RAF settings.

Conclusions:

  • Limited RAF abundance represents a common yet understudied signaling regime in cancer.
  • RAF bottlenecks can impair EGFR-ERK pathway activation and may influence responses to oncogenic RAS mutations.
  • Computational modeling provides a powerful framework for understanding complex signaling dynamics and identifying therapeutic targets.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.8K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.3K